Working… Menu

Setmelanotide for the Treatment of LEPR Deficiency Obesity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03287960
Recruitment Status : Completed
First Posted : September 19, 2017
Last Update Posted : January 27, 2021
Information provided by (Responsible Party):
Rhythm Pharmaceuticals, Inc.